| |
| |
|
| Insider
Information: |
Kumar Ravindra |
| Relationship: |
SVP & Chief Scientific... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
86,986 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15,548,748 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
86,986 |
|
|
| Total
Value |
$15,548,748 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
SVP & Chief Scientific... |
2019-09-10 |
86,986 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
60 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific OfficerO |
• – – |
2013-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
47,890 |
|
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-04-22 |
4 |
AS |
$35.86 |
$71,720 |
D/D |
(2,000) |
45,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-05-19 |
4 |
AS |
$31.23 |
$282,232 |
D/D |
(9,000) |
41,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-05-19 |
4 |
OE |
$5.88 |
$29,400 |
D/D |
5,000 |
50,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-06-02 |
4 |
AS |
$29.72 |
$59,440 |
D/D |
(2,000) |
39,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-06-20 |
4 |
OE |
$5.88 |
$29,400 |
D/D |
5,000 |
44,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-06-20 |
4 |
AS |
$35.00 |
$245,000 |
D/D |
(7,000) |
37,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-07-01 |
4 |
AS |
$34.10 |
$68,200 |
D/D |
(2,000) |
35,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-08-14 |
4 |
AS |
$29.85 |
$269,700 |
D/D |
(9,000) |
31,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-08-14 |
4 |
OE |
$5.88 |
$29,400 |
D/D |
5,000 |
38,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-09-02 |
4 |
OE |
$5.88 |
$11,760 |
D/D |
2,000 |
33,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-09-02 |
4 |
AS |
$26.40 |
$52,800 |
D/D |
(2,000) |
31,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-09-30 |
4 |
AS |
$30.00 |
$210,000 |
D/D |
(7,000) |
29,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-09-30 |
4 |
OE |
$5.28 |
$27,300 |
D/D |
5,000 |
36,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-10-01 |
4 |
AS |
$29.57 |
$118,760 |
D/D |
(4,000) |
29,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-10-01 |
4 |
OE |
$5.88 |
$23,520 |
D/D |
4,000 |
33,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-11-12 |
4 |
AS |
$32.46 |
$132,480 |
D/D |
(4,000) |
29,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-11-12 |
4 |
OE |
$5.88 |
$23,520 |
D/D |
4,000 |
33,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-11-13 |
4 |
AS |
$35.00 |
$420,000 |
D/D |
(12,000) |
27,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-11-13 |
4 |
OE |
$5.28 |
$55,800 |
D/D |
10,000 |
39,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-12-01 |
4 |
AS |
$34.87 |
$143,537 |
D/D |
(4,000) |
27,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-12-01 |
4 |
OE |
$5.88 |
$23,520 |
D/D |
4,000 |
31,890 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2014-12-19 |
4 |
OE |
$0.92 |
$14,151 |
D/D |
9,810 |
37,700 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2015-01-02 |
4 |
AS |
$38.36 |
$153,844 |
D/D |
(4,000) |
37,700 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2015-01-02 |
4 |
OE |
$5.88 |
$23,520 |
D/D |
4,000 |
41,700 |
0 |
- |
|
60 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
